A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 14, 2021

Primary Completion Date

July 24, 2021

Study Completion Date

July 24, 2021

Conditions
Healthy
Interventions
DRUG

Lasmiditan

Administered orally.

Trial Locations (1)

75247

Covance Dallas, Dallas

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY